The documented benefits extend beyond theoretical longevity: improved sleep quality and circadian rhythm regulation through pineal gland support, enhanced immune function markers, normalized melatonin production in aging individuals, reduced oxidative stress, improved skin elasticity and appearance, and potential disease prevention through cellular optimization
Achieve Glowing Skin
Available: (accessed 2019 Apr
Outcomes Compared with the SGLT2 inhibitors group, there was no evidence that the GLP-1RAs group was associated with the following outcomes: (1) the new onset of heart failure (HR 0.97
As of March 2026, just 13 state Medicaid programs cover GLP-1 medications, including Ozempic, for obesity treatment: Delaware Kansas Massachusetts Michigan Minnesota Mississippi Missouri North Carolina Rhode Island Tennessee Utah Virginia Wisconsin Medicaid programs in California, New Hampshire, Pennsylvania, and South Carolina all recently ended obesity drug coverage, citing the steep cost of these medications